-
Jan 18, 2025 | 
myscience.be | Vrije Universiteit Brussel
An international team led by Belgian scientists has recovered 115 Antarctic meteorites weighing more than 2 kg (in total) during the ongoing 2024-2025 BELgian Antarctic Research Expedition (BELARE).
-
Jan 18, 2025 | 
myscience.org | Vrije Universiteit Brussel
An international team led by Belgian scientists has recovered 115 Antarctic meteorites weighing more than 2 kg (in total) during the ongoing 2024-2025 BELgian Antarctic Research Expedition (BELARE).
-
Jan 15, 2025 | 
bmcgenomics.biomedcentral.com | Vrije Universiteit Brussel
In this study, we found that the number of olfactory-related genes identified in L. entomophila (26), L. decolor (47), and L. yangi (34) by transcriptome data alone is significantly less than those of L. bostrychophila (94) and L. tricolor (118) analyzed by genome data. This finding demonstrates the advantages of genome-wide approaches over transcriptome-based methods in understanding olfactory systems of booklice. Among them, the difference in the number of ORs and IRs is the most pronounced.
-
Jan 15, 2025 | 
myscience.be | Vrije Universiteit Brussel
The Vrije Universiteit Brussel (VUB) launches the fourth edition of the Expert Class in Cycling Management today. Over twelve Thursdays and a three-day international study trip, participants will delve into the world of the cycling industry. This program, a collaboration between VUB, the Faculty of Physical Education and Physiotherapy, and Sportcareers, offers fresh insights into the business and organizational side of cycling.
-
Jan 13, 2025 | 
myscience.be | Vrije Universiteit Brussel
The press is warmly invited to a double lecture by world authority on multilingualism research Jean-Marc Dewaele and philosopher and Chair of the Brussels Council for Multilingualism Philippe Van Parijs.
-
Dec 19, 2024 | 
myscience.be | Vrije Universiteit Brussel
VUB Research Team Presents Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in collaboration with leading German universities, has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone healing and tumor control.
-
Dec 9, 2024 | 
jamanetwork.com | Brandon Heidinger |Kenneth Chambaere |Vrije Universiteit Brussel |Eliana Close
International Comparison of Underlying Disease Among Recipients of Medical Assistance in Dying In 2023, 282 million individuals lived in jurisdictions allowing medical assistance in dying (MAID).
-
Dec 9, 2024 | 
myscience.org | Vrije Universiteit Brussel
Brussels, December 9, 2024 - Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and various other diseases. However, the therapeutic effectiveness is limited by the poor translation uptake of naked mRNA. Researchers from VIB, VUB, Ghent University and eTheRNA Immunotherapies developed an immunotherapeutic platform based on lipid-based nanoparticles (LNPs) to circumvent this challenge.
-
Dec 9, 2024 | 
myscience.be | Vrije Universiteit Brussel
Brussels, December 9, 2024 - Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and various other diseases. However, the therapeutic effectiveness is limited by the poor translation uptake of naked mRNA. Researchers from VIB, VUB, Ghent University and eTheRNA Immunotherapies developed an immunotherapeutic platform based on lipid-based nanoparticles (LNPs) to circumvent this challenge.
-
Dec 5, 2024 | 
myscience.be | Vrije Universiteit Brussel
The Vrije Universiteit Brussel (VUB) and VIB have joined forces to launch the brand-new Bio Incubator Brussels (BIB) on the green VUB Main Campus in Etterbeek. This innovative hub brings together science, technology, and entrepreneurship to transform groundbreaking biotechnological advancements into new companies. Start-ups in the fields of biotechnology, pharmaceuticals, and health technology can now utilize this facility, which offers ready-to-use lab and office spaces.
